SPRINGWORKS THERAPEUTICS, INC. Marketable Securities (Non-Current)
SPRINGWORKS THERAPEUTICS, INC. had Marketable Securities (Non-Current) of $94.78 million as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:MarketableSecuritiesNoncurrent · last filed 2025-05-09
- 2025-03-31: Marketable Securities, Noncurrent $94.78M.
- 2024-12-31: Marketable Securities, Noncurrent $153.93M.
- 2024-09-30: Marketable Securities, Noncurrent $121.50M.
- 2024-06-30: Marketable Securities, Noncurrent $138.05M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2025-03-31 | $94.78M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $153.93M 10-Q · filed 2025-05-09 |
| 2024-09-30 | $121.50M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $138.05M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $136.40M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $183.39M 10-K · filed 2025-02-20 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-02 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-03 |
| 2022-12-31 | $4.79M 10-K · filed 2024-02-27 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 |
| 2022-03-31 | $32.48M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $59.23M 10-K · filed 2023-02-28 |
| 2021-09-30 | $52.73M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $44.71M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $63.63M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $53.34M 10-K · filed 2022-02-24 |